Saegis Pharmaceuticals
Half Moon Bay, United States · Founded 1999 · $30.0M raised
- Headquarters
- Half Moon Bay, California
- Employees
- 1–10
- Founded
- 1999
- Business Model
- B2B
- Website
- saegispharma.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series B
- Rounds
- 1
About
Saegis Pharmaceuticals was a clinical-stage CNS drug discovery company that developed small molecule therapeutics for behavioral and cognitive disorders including Alzheimer's-associated dementia, mild cognitive impairment, ADHD, and schizophrenia. The company's lead candidate, SGS518, was a novel 5HT6 serotonin receptor antagonist being evaluated for Cognitive Impairment Associated with Schizophrenia (CIAS). Saegis raised a total of approximately $30 million in venture funding before being acquired by Danish pharmaceutical company Lundbeck in 2006, which continued development of its CNS pipeline assets.
Summary
Saegis Pharmaceuticals is a Biotech company based in Half Moon Bay, United States, founded in 1999. It has raised $30.0M in total across 1 round. Investors include Versant Ventures, Technology Partners and Polaris Partners.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/saegis-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/saegis-pharmaceuticals" alt="Saegis Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>